Let Your Doctor Know You Are Interested in Once-weekly SKYTROFA® Today

Get started with SKYTROFA Choice

Hero Image

Interested to see if SKYTROFA is right for your child?

We've partnered with ProCare Pharmacy Care to help streamline your journey. Follow these 3 easy steps to let your doctor know about your interest in SKYTROFA.

One Icon

Click "Send a request to your doctor today" to begin your registration with ProCare Pharmacy Care. This is the first step to express your interest, ensuring your information reaches your child's doctor securely and promptly

Two Icon
Answer a Few Questions

Respond to a short questionnaire to help us better understand your needs

3 Icon
Select Your Child's Doctor

Choose your child's doctor from the list. Then, ProCare Pharmacy Care will securely forward your request. Your doctor will evaluate if SKYTROFA is a suitable option for your child

What happens next?
Once your doctor receives and reviews your request, you will be notified about the next steps.

Features of SKYTROFA

Icon of a big and small person

More injection-free days compared with daily therapies

X Icon

Higher growth rate after 1 year in a clinical trial compared with a daily somatropin therapy

Bone Icon

Convenient storage with no required refrigeration for up to 6 months* and preservative free

Bone Icon

Clinical data for pediatric patients switching from a daily somatropin to SKYTROFA

Established safety profile

  • In a clinical study, some children taking once-weekly SKYTROFA had mild injection-site reactions
  • Side effects occurring more frequently than with daily somatropin included viral infection, fever, cough, nausea and vomiting, bleeding, diarrhea, stomach area pain, and joint pain and arthritis

* Store SKYTROFA in the original package to protect from light. Do not freeze. SKYTROFA can be stored at room temperature (not to exceed 86°F [30°C]) for up to 6 months. Alternatively, SKYTROFA can be stored under refrigeration at 36°F to 46°F (2°C to 8°C) until the expiration date. If refrigerated, keep at room temperature for 15 minutes before use. Do not use SKYTROFA beyond the expiration date or 6 months after the date it was first removed from refrigeration (whichever is earlier).

In a clinical trial that compared once-weekly SKYTROFA with a daily somatropin in 161 children with pediatric GHD who previously had not been on treatment. The primary endpoint from the clinical trial was annualized height velocity (AHV) at 52 weeks. AHV at 52 weeks was 11.2 cm/year for SKYTROFA versus 10.3 cm/year for a daily somatropin.

SKYTROFA was studied in a 26-week clinical trial investigating the safety, tolerability, and efficacy of SKYTROFA administered once weekly in children with pediatric GHD. The trial included 3 children who previously had not been on treatment and 143 children previously treated with daily growth hormone therapies for ≤ 130 weeks. Safety and tolerability were the primary endpoints.

SKYTROFA dosing considerations

The recommended dose of SKYTROFA for treatment-naïve patients and patients switching from daily somatropin therapy is 0.24 mg/kg body weight, given once weekly.

  • Your healthcare provider will individualize and adjust the dosage of SKYTROFA based on response
  • When changing from daily somatropin therapy to once-weekly SKYTROFA, you should wait at least 8 hours between the final dose of daily somatropin and the first dose of once-weekly SKYTROFA
Nurse at table with family discussing SKYTROFA